Russo Partners

🎧 solomon wilcots of Russo Partners chats with Dr. Graig Suvannavejh of Mizuho about why this is such an exciting time to be a part of the biotech and pharma industry. From transformative advancements in cancer and Alzheimer’s research to groundbreaking metabolic treatments, Graig shares insights on redefining biotech’s global impact on health. Listen here: https://bit.ly/3BVpE4G Apple Podcasts: https://apple.co/4dVG0Yd Spotify: https://spoti.fi/48uMCvx YouTube: https://bit.ly/40mqC3Z #Biotech #Biopharma #Investors #InvestorPodcast

🚀 Dive into the future of biotech innovation with David Bearss Ph.D., Co-Founder & CEO of Halia Therapeutics, Inc., in this episode of Biotech 2050! Dr. Bearss shares how Halia is driving biotech innovation with groundbreaking genetic research aimed at addressing unmet medical needs like Alzheimer’s disease. From tackling neuroinflammation to pioneering new therapies for neurodegenerative disorders, this episode is packed with cutting-edge insights. Listen here: https://bit.ly/40u7v8p #Alzheimers #Neurodegeneration #Innovation

Endpoints News reports #biotech deals are on track to surpass 2023 as of Q3, thanks to robust AI-driven partnerships and steady venture funding totaling close to $21B. Q3 also saw 16 IPOs raise $3B—already topping last year’s $2.7B. But to exceed last year’s totals, Q4 will need a typical late-year spike in licensing and M&A activity. AI services alone contributed to 139 service deals this year, while M&A remains cautious with 28 deals worth $15.6B in Q3. Read more: https://lnkd.in/eNAg9sDy #VC #Financing

Lucid Diagnostics' innovative campaign, highlighted in MM+M, uses an unusual mascot, Freddy the Food Tube, and former NFL players to raise awareness about esophageal cancer. With support from Russo Partners Sports-Health Alliance, led by solomon wilcots, the campaign connects with high-risk groups, including former players, to promote early detection through the EsoGuard test. https://bit.ly/4fJURqj #EsophagealCancer #HealthcareAwareness #EarlyDetection

In this episode of the Russo Edge Podcast with host solomon wilcots, Graig Suvannavejh, PhD, of Mizuho highlights what’s driving biotech and pharm investments. Graig highlights obesity as a central focus, with companies strategizing around approaches like GLP-1 and beyond. He explains that the future could see novel therapies targeting mechanisms like myostatin inhibition, CB1 receptors, and even the inflammasome. Listen here: https://bit.ly/3BVpE4G Apple Podcasts: https://apple.co/4dVG0Yd Spotify: https://spoti.fi/48uMCvx YouTube: https://bit.ly/40mqC3Z #Biotech #Biopharma #Investors #InvestorPodcast

Don't miss this compelling discussion led by David Schull at #BioFuture2024 on #AI.

In biotech, communications are everything. In his latest article, our CEO, Tony Russo, Ph.D., dives into how early-stage biotech companies can stand out with clear, compelling messages that resonate with key stakeholders. At Russo Partners, we show you how a strategic communications plan can build credibility, attract investment, and keep your company on track for success. Read the full article on LinkedIn: https://bit.ly/48GreUx #CommunicationsStrategy #LifeSciences

🎧 solomon wilcots of Russo Partners chats with Graig Suvannavejh, PhD, of Mizuho for his expert insight into what biotech and biopharma investments will look like at the end of this year. Graig shares his insights on the evolving biotech sector, the impact of high interest rates on smaller companies, and emerging therapeutic areas poised for growth. Don't miss this in-depth discussion on the future of biotech investing. To listen to the episode, visit: https://bit.ly/3BVpE4G Apple Podcasts: https://apple.co/4dVG0Yd YouTube: https://bit.ly/4f8JxDS #Biotech #Biopharma #Investors #InvestorPodcast

The #AI revolution in healthcare is making waves in New York’s #HealthTech market, with venture capital investments already surpassing $1 billion in 2024. From drug discovery to streamlining administrative tasks like insurance claims, AI is helping to solve long-standing challenges. Read more from Modern Healthcare: https://bit.ly/3Aeqnxg #Innovation #HealthcareAI #VC

Thanks so much to former NFL-er, sports announcer, and all-around great guy solomon wilcots and the team at Russo Partners for recently having me as a guest on the Russo Edge podcast for a lively discussion on the biotech sector. We explored the evolving biotech landscape, upcoming events and catalysts, and key therapeutic areas poised for growth, and we also touched on best practices for companies looking to strengthen relationships with research analysts and investors. @Mizuho #ThisIsMizuho